Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in SEC Reports and is not so disclosed and would have or reasonably be expected to result in a Material Adverse Effect.
Appears in 64 contracts
Samples: Securities Purchase Agreement (Atara Biotherapeutics, Inc.), Securities Purchase Agreement (Fluent, Inc.), Securities Purchase Agreement (Rallybio Corp)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in SEC Reports its Exchange Act filings and is not so disclosed and would have or reasonably be expected to result in have a Material Adverse Effect.
Appears in 24 contracts
Samples: Securities Purchase Agreement (Root9B Technologies, Inc.), Securities Purchase Agreement (Root9B Holdings, Inc.), Securities Purchase Agreement (MidWestOne Financial Group, Inc.)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in SEC Reports its Commission Documents and is not so disclosed and or that otherwise would be reasonably likely to have or reasonably be expected to result in a Material Adverse Effect.
Appears in 18 contracts
Samples: Note and Warrant Purchase Agreement (Vision Capital Advisors, LLC), Note and Warrant Purchase Agreement (Vision Capital Advisors, LLC), Note and Warrant Purchase Agreement (Vision Capital Advisors, LLC)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be not disclosed by the Company in SEC Reports and is not so disclosed and its Financial Statements or that otherwise would be reasonably likely to have or reasonably be expected to result in a Material Adverse Effect.
Appears in 17 contracts
Samples: Securities Purchase Agreement (GridIron BioNutrients, Inc.), Securities Purchase Agreement (Lord Global Corp), Equity Line Purchase Agreement (Endonovo Therapeutics, Inc.)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in SEC Reports its Exchange Act filings and is not so disclosed and would have or reasonably be expected to result in a Material Adverse Effect.
Appears in 12 contracts
Samples: Securities Purchase Agreement (Citizens Community Bancorp Inc.), Securities Purchase Agreement (First Bancshares Inc /MS/), Securities Purchase Agreement (First Bancshares Inc /MS/)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its SEC Reports Documents and is not so disclosed and or that otherwise would be reasonably likely to have or reasonably be expected to result in a Material Adverse Effect.
Appears in 11 contracts
Samples: Share Purchase Agreement (India Globalization Capital, Inc.), Purchase Agreement (India Globalization Capital, Inc.), Securities Purchase Agreement (Adept Technology Inc)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its SEC Reports and is not so disclosed and or that otherwise would be reasonably likely to have or reasonably be expected to result in a Material Adverse Effect.
Appears in 10 contracts
Samples: Securities Purchase Agreement (Cleanspark, Inc.), Securities Purchase Agreement (Kintera Inc), Securities Purchase Agreement (Crdentia Corp)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) of its Subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its SEC Reports Documents and is not so disclosed and would or that otherwise could be reasonably likely to have or reasonably be expected to result in a Material Adverse Effect.
Appears in 10 contracts
Samples: Share Purchase Agreement (LakeShore Biopharma Co., Ltd.), Share Purchase Agreement (Wong Fung Ching), Securities Purchase Agreement (ONCOSEC MEDICAL Inc)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its SEC Reports and is not so disclosed and would have or reasonably be expected to result in a Material Adverse Effect.
Appears in 10 contracts
Samples: Securities Purchase Agreement (Mri Interventions, Inc.), Securities Purchase Agreement (Mri Interventions, Inc.), Securities Purchase Agreement (Mri Interventions, Inc.)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in SEC Reports its Exchange Act filings and is not so disclosed and or that otherwise would be reasonably likely to have or reasonably be expected to result in a Material Adverse Effect.
Appears in 9 contracts
Samples: Securities Purchase Agreement (S&W Seed Co), Securities Purchase Agreement (S&W Seed Co), Securities Purchase Agreement (S&W Seed Co)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its SEC Reports (including, for purposes hereof, any that are required to be disclosed in a Form 10) and is not so disclosed and or that otherwise would have or reasonably be expected to result in a Material Adverse Effect.
Appears in 9 contracts
Samples: Securities Purchase Agreement (Hudson Executive Capital LP), Securities Purchase Agreement (Corindus Vascular Robotics, Inc.), Securities Purchase Agreement (Corindus Vascular Robotics, Inc.)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) subsidiary and an unconsolidated or other off off-balance sheet entity that is required to be disclosed by the Company in its SEC Reports (including, for purposes hereof, any that are required to be disclosed in a Form 10) and is not so disclosed and or that otherwise would have or reasonably be expected to result in a Material Adverse Effect.
Appears in 8 contracts
Samples: Subscription Agreement (Wrap Technologies, Inc.), Subscription Agreement (Wrap Technologies, Inc.), Subscription Agreement (Wrap Technologies, Inc.)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or Company, any Subsidiary) Subsidiary and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in the SEC Reports and is not so disclosed and would have or reasonably be expected to result in a Material Adverse Effect.
Appears in 8 contracts
Samples: Securities Purchase Agreement (Transgenomic Inc), Securities Purchase Agreement (Transgenomic Inc), Securities Purchase Agreement (Bacterin International Holdings, Inc.)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, arrangement or other relationship between the Company (or any Subsidiary) Subsidiary and an unconsolidated or other off off-balance sheet entity that is required to have been described under applicable securities laws in the SEC Reports that is not so disclosed or that otherwise would be reasonably likely to have a Material Adverse Effect. There are no such transactions, arrangements or other relationships with the Company or any Subsidiary that may create contingencies or liabilities that have not been otherwise disclosed by the Company in the SEC Reports and is not so disclosed and would have or reasonably be expected to result in a Material Adverse EffectReports.
Appears in 8 contracts
Samples: Purchase Agreement (HealthCare Ventures IX, L.P.), Purchase Agreement (Leap Therapeutics, Inc.), Placement Agency Agreement (PLx Pharma Inc.)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off off-balance sheet entity that is required to be disclosed by the Company in its SEC Reports (including, for purposes hereof, any that are required to be disclosed in a Form 10) and is not so disclosed and or that otherwise would have or reasonably be expected to result in a Material Adverse Effect.
Appears in 7 contracts
Samples: Series B Preferred Stock and Warrant Purchase Agreement (Viveve Medical, Inc.), Series B Preferred Stock Purchase Agreement (Valeritas Holdings Inc.), Series a Preferred Stock Purchase Agreement (Avinger Inc)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its SEC Reports and is not so disclosed and or that otherwise would have or reasonably be expected to result in a Material Adverse Effect.
Appears in 7 contracts
Samples: Securities Purchase Agreement (Torchlight Energy Resources Inc), Securities Purchase Agreement (Torchlight Energy Resources Inc), Securities Purchase Agreement (COMMITTED CAPITAL ACQUISITION Corp)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) of its Subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its SEC Reports and is not so disclosed and would or that otherwise could be reasonably likely to have or reasonably be expected to result in a Material Adverse Effect.
Appears in 6 contracts
Samples: Form of Securities Purchase Agreement (Ampio Pharmaceuticals, Inc.), Common Stock Purchase Agreement (Lantronix Inc), Securities Purchase Agreement (Boldface Group, Inc.)
Off-Balance Sheet Arrangements. There Except as would not have or reasonably be expected to result in a Material Adverse Effect, there is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in SEC Reports Filings and is not so disclosed and would have or reasonably be expected to result in a Material Adverse Effectdisclosed.
Appears in 6 contracts
Samples: Common Stock Purchase Agreement (G42 Investments AI Holdings RSC Ltd.), Common Stock Purchase Agreement (vTv Therapeutics Inc.), Securities Purchase Agreement (Spectrum Pharmaceuticals Inc)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its SEC Reports and is not so disclosed and would have or reasonably be expected to result in have a Material Adverse Effect.
Appears in 6 contracts
Samples: Securities Purchase Agreement (Newbridge Bancorp), Securities Purchase Agreement (Ecb Bancorp Inc), Securities Purchase Agreement (Ecb Bancorp Inc)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in the SEC Reports and is not so disclosed and would have or reasonably be expected to result in a Material Adverse Effectdisclosed.
Appears in 6 contracts
Samples: Securities Purchase Agreement (NeurogesX Inc), Securities Purchase Agreement (NeurogesX Inc), Securities Purchase Agreement (Yayi International Inc)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) of its subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in the SEC Reports Documents and is not so disclosed and would or that otherwise could be reasonably likely to have or reasonably be expected to result in a Material Adverse Effect.
Appears in 6 contracts
Samples: Securities Purchase Agreement (Nuburu, Inc.), Securities Purchase Agreement (Nuburu, Inc.), Securities Purchase Agreement (Mullen Automotive Inc.)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) of its Subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in the SEC Reports Documents and is not so disclosed and would or that otherwise could be reasonably likely to have or reasonably be expected to result in a Material Adverse Effect.
Appears in 5 contracts
Samples: Securities Purchase Agreement (Borqs Technologies, Inc.), Securities Purchase Agreement (Borqs Technologies, Inc.), Securities Purchase Agreement (Borqs Technologies, Inc.)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, arrangement or other relationship between the Company (or any Subsidiary) Subsidiary and an unconsolidated or other off off-balance sheet entity that (a) is required to be disclosed by have been described under applicable securities laws in the Company in SEC Reports and that is not so disclosed and or (b) otherwise would have or be reasonably be expected likely to result in a Material Adverse Effect. There are no such transactions, arrangements or other relationships with the Company or any Subsidiary that may create material contingencies or liabilities that have not been otherwise disclosed by the Company in the SEC Reports as required by applicable law.
Appears in 5 contracts
Samples: Exchange Agreement (Teligent, Inc.), Exchange Agreement (Teligent, Inc.), Exchange Agreement (Teligent, Inc.)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, arrangement or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off off-balance sheet entity that is required to be disclosed by the Company in its SEC Reports and is not so disclosed and or that otherwise would be reasonably likely to have or reasonably be expected to result in a Material Adverse Effect. There are no such transactions, arrangements or other relationships with the Company that may create contingencies or liabilities that are not otherwise disclosed by the Company in its SEC Reports.
Appears in 5 contracts
Samples: Indemnification Agreement (Ophthalmic Imaging Systems), Indemnification Agreement (Ophthalmic Imaging Systems), Indemnification Agreement (Ophthalmic Imaging Systems)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its SEC Reports and is not so disclosed and would have or reasonably be expected to result in a Material Adverse Effectdisclosed.
Appears in 5 contracts
Samples: Subscription Agreement (Evergreen Sustainable Enterprises, Inc.), Subscription Agreement (Generation Hemp, Inc.), Subscription Agreement (Generation Hemp, Inc.)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in the SEC Reports Documents and is not so disclosed and or that otherwise would be reasonably likely to have or reasonably be expected to result in a Material Adverse Effect.
Appears in 5 contracts
Samples: Security Purchase Agreement (Amyris, Inc.), Securities Purchase Agreement (RedHill Biopharma Ltd.), Securities Purchase Agreement (Minerva Neurosciences, Inc.)
Off-Balance Sheet Arrangements. There Except as otherwise provided in the SEC Documents, there is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in SEC Reports its Exchange Act filings and is not so disclosed and or that otherwise would be reasonably likely to have or reasonably be expected to result in a Material Adverse Effect.
Appears in 5 contracts
Samples: Securities Purchase Agreement (China Shuangji Cement Ltd.), Securities Purchase Agreement (China Shuangji Cement Ltd.), Securities Purchase Agreement (China Power Equipment, Inc.)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in SEC Reports and is not so disclosed and or that otherwise would have be reasonably likely to have, individually or reasonably be expected to result in the aggregate, a Material Adverse Effect. There are no such transactions, arrangements or other relationships with the Company that may create contingencies or liabilities that are not otherwise disclosed by the Company in its Exchange Act filings.
Appears in 5 contracts
Samples: Exchange Agreement (Bovie Medical Corp), Securities Purchase Agreement (Bovie Medical Corp), Securities Purchase Agreement (Health Revenue Assurance Holdings, Inc.)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its SEC Reports and is not so disclosed and or that otherwise would be reasonably likely to have or reasonably be expected to result in a Material Adverse EffectEffect with respect to the Company.
Appears in 4 contracts
Samples: Common Stock Purchase Agreement (Pacific Mercantile Bancorp), Stock Purchase Agreement (Pacific Mercantile Bancorp), Stock Purchase Agreement (Pacific Mercantile Bancorp)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, arrangement or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off off-balance sheet entity that is required to be disclosed by the Company in its Company SEC Reports Documents and is not so disclosed and or that otherwise would be reasonably likely to have or reasonably be expected to result in a Material Adverse Effect. There are no such transactions, arrangements or other relationships with the Company that may create contingencies or liabilities that are not otherwise disclosed by the Company in its Company SEC Documents.
Appears in 4 contracts
Samples: Investment Agreement (Guaranty Financial Group Inc.), Securities Purchase Agreement (Mission Community Bancorp), Investment Agreement (Guaranty Financial Group Inc.)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off off-balance sheet entity that is required to be disclosed by the Company in its SEC Reports and is not so disclosed and or that otherwise would have or reasonably be expected to result in a Material Adverse Effect.
Appears in 4 contracts
Samples: Securities Purchase Agreement (Avinger Inc), Securities Purchase Agreement (Avinger Inc), Securities Purchase Agreement (Avinger Inc)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) of its Subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in SEC Reports its filings, if any, pursuant to Securities Laws and is not so disclosed and would or that otherwise could be reasonably likely to have or reasonably be expected to result in a Material Adverse Effect.
Appears in 4 contracts
Samples: Subscription Agreement (Canopy Growth Corp), Subscription Agreement (Canopy Growth Corp), Subscription Agreement (Canopy Growth Corp)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) subsidiary and an unconsolidated or other off off-balance sheet entity that is required to be disclosed by the Company in its SEC Reports and is not so disclosed and or that otherwise would have or reasonably be expected to result in a Material Adverse Effect.
Appears in 4 contracts
Samples: Subscription Agreement (Amesite Inc.), Subscription Agreement (Sincerity Applied Materials Holdings Corp.), Subscription Agreement (Hyperdynamics Corp)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in the Company's SEC Reports Filings and is not so disclosed and or that otherwise would have or reasonably be expected to result in a Material Adverse Effect.
Appears in 4 contracts
Samples: Amended and Restated Agreement (Document Security Systems Inc), Amended and Restated Agreement (Raser Technologies Inc), Agreement (Sanders Morris Harris Group Inc)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in SEC Reports and is not so disclosed and would have or reasonably be expected to result in a Material Adverse Effectdisclosed.
Appears in 3 contracts
Samples: Securities Purchase Agreement (Gemphire Therapeutics Inc.), Securities Purchase Agreement (Kythera Biopharmaceuticals Inc), Securities Purchase Agreement (OncoMed Pharmaceuticals Inc)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in SEC Reports Filings and is not so disclosed and would have or reasonably be expected to result in a Material Adverse Effect.
Appears in 3 contracts
Samples: Securities Purchase Agreement (Selecta Biosciences Inc), Securities Purchase Agreement (MEI Pharma, Inc.), Registration Rights Agreement (Aveo Pharmaceuticals Inc)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) of its Subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in SEC its Public Reports and is not so disclosed and would or that otherwise could be reasonably likely to have or reasonably be expected to result in a Material Adverse Effect.
Appears in 3 contracts
Samples: Securities Purchase Agreement (Bioheart, Inc.), Securities Purchase Agreement (Bioheart, Inc.), Securities Purchase Agreement (Bioheart, Inc.)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in SEC Reports and is not so disclosed and would have or reasonably be expected to result in a Material Adverse Effect.
Appears in 3 contracts
Samples: Securities Purchase Agreement (Z Trim Holdings, Inc), Securities Purchase Agreement (Tengion Inc), Securities Purchase Agreement (Tengion Inc)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in the Company’s SEC Reports Filings and is not so disclosed and or that otherwise would have or reasonably be expected to result in a Material Adverse Effect.
Appears in 3 contracts
Samples: Agreement (Syntroleum Corp), Securities Purchase Agreement (United Community Banks Inc), Securities Purchase Agreement (Calera Capital Management IV Inc)
Off-Balance Sheet Arrangements. There Except as set forth in the SEC Documents, there is no transaction, arrangement, arrangement or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in SEC Reports its Exchange Act filings and is not so disclosed and would have or reasonably be expected to result in a Material Adverse Effectdisclosed.
Appears in 3 contracts
Samples: Common Stock Subscription Agreement, Securities Purchase Agreement (Eco-Stim Energy Solutions, Inc.), Common Stock Subscription Agreement (Eco-Stim Energy Solutions, Inc.)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in the Company SEC Reports Documents and is not so disclosed and or that otherwise would be reasonably likely to have or reasonably be expected to result in a Material Adverse Effect.
Appears in 3 contracts
Samples: Standby Purchase Agreement (Trade Street Residential, Inc.), Standby Purchase Agreement (Trade Street Residential, Inc.), Standby Purchase Agreement (Trade Street Residential, Inc.)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in the SEC Reports Documents and is not so disclosed and would or that otherwise could be reasonably likely to have or reasonably be expected to result in a Material Adverse Effect.
Appears in 3 contracts
Samples: Securities Purchase Agreement (Skyline Medical Inc.), Securities Purchase Agreement (Tanzanian Royalty Exploration Corp), Securities Purchase Agreement (Cempra, Inc.)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) of its Subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in the SEC Reports Documents and is not so disclosed or that otherwise would be reasonably likely to be material to the Company and would have or reasonably be expected to result in its Subsidiaries, taken as a Material Adverse Effectwhole.
Appears in 3 contracts
Samples: Purchase Agreement (Oncobiologics, Inc.), Exchange Agreement (Oncobiologics, Inc.), Purchase Agreement (Oncobiologics, Inc.)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its SEC Reports Filings and is not so disclosed and or that otherwise would have or reasonably be expected to result in a Material Adverse Effect.
Appears in 3 contracts
Samples: Agreement (Medient Studios, Inc.), Agreement (Ants Software Inc), Agreement (Ants Software Inc)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or Company, any Subsidiary) Subsidiary and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in the SEC Reports and is not so disclosed and would have or reasonably be expected to result in a Material Adverse Effectdisclosed.
Appears in 3 contracts
Samples: Securities Purchase Agreement (NeuroBo Pharmaceuticals, Inc.), Stock and Warrant Purchase Agreement (Stereotaxis, Inc.), Securities Purchase Agreement (Scientific Learning Corp)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, arrangement or other relationship between the Company (or any Subsidiary) its subsidiaries and an unconsolidated or other off off-balance sheet entity that is required to be disclosed by the Company in the Company SEC Reports Documents and is not so disclosed. There are no such transactions, arrangements or other relationships with the Company that may create contingencies or liabilities that are not otherwise disclosed and would have or reasonably be expected to result by the Company in a Material Adverse Effect.the Company SEC Documents;
Appears in 2 contracts
Samples: Subscription Agreement (Tel Instrument Electronics Corp), Subscription Agreement (Tel Instrument Electronics Corp)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) Subsidiary and an unconsolidated or other off off-balance sheet entity that is required to be disclosed by the Company in its SEC Reports (including, for purposes hereof, any that are required to be disclosed in a Form 10) and is not so disclosed and would have or reasonably be expected to result in a Material Adverse Effectdisclosed.
Appears in 2 contracts
Samples: Subscription Agreement (Augmedix, Inc.), Subscription Agreement (Compass Therapeutics, Inc.)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off off-balance sheet entity that is required to be disclosed by the Company in SEC Reports and is not so disclosed and would have or reasonably be expected to result in a Material Adverse Effectdisclosed.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Biodesix Inc), Securities Purchase Agreement (Biodesix Inc)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or Company, any Subsidiary) Subsidiary and an unconsolidated or other off off-balance sheet entity that is required to be disclosed by the Company in the SEC Reports and is not so disclosed and would have or reasonably be expected to result in a Material Adverse Effect.
Appears in 2 contracts
Samples: Share Purchase Agreement (Capricor Therapeutics, Inc.), Share Purchase Agreement (Capricor Therapeutics, Inc.)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off off-balance sheet entity that is required to be disclosed by the Company in its SEC Reports Filings (including, for purposes hereof, any that are required to be disclosed in a Form 10) and is not so disclosed and or that otherwise would have or reasonably be expected to result in a Material Adverse Effect.
Appears in 2 contracts
Samples: Subscription Agreement (Enumeral Biomedical Holdings, Inc.), Subscription Agreement (Enumeral Biomedical Holdings, Inc.)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in the SEC Reports Documents and is not so disclosed and would have or reasonably be expected to result in a Material Adverse Effectdisclosed.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Kv Pharmaceutical Co /De/), Securities Purchase Agreement (Sequenom Inc)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in SEC Reports its Exchange Act filings and is not so disclosed and or that otherwise would have or be reasonably be expected likely to result in have a Material Adverse Effect.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Celator Pharmaceuticals Inc), Securities Purchase Agreement (Gse Systems Inc)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in the SEC Reports and is not so disclosed and would have or reasonably be expected to result in a Material Adverse Effectdisclosed.
Appears in 2 contracts
Samples: Securities Purchase Agreement (First Mid Illinois Bancshares Inc), Securities Purchase Agreement (F&m Bank Corp)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, arrangement or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off off-balance sheet entity that is required to be disclosed by the Company in the SEC Reports Documents and is not so disclosed and would or that otherwise could be reasonably likely to have or reasonably be expected to result in a Material Adverse Effect. There are no such transactions, arrangements or other relationships with the Company that may create contingencies or liabilities that are not otherwise disclosed by the Company in the SEC Documents.
Appears in 2 contracts
Samples: Purchase Agreement (Abengoa Sa), Form of Purchase Agreement (Telvent Git S A)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, arrangement or other relationship between the Company (or any Subsidiary) of its Subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in the SEC Reports and is not so disclosed and would disclosed, except as could not have or reasonably be expected to result in a Material Adverse Effect.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Galmed Pharmaceuticals Ltd.), Securities Purchase Agreement (Galmed Pharmaceuticals Ltd.)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) of its Subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in SEC Reports its Securities Act filings and is not so disclosed and would or that otherwise could be reasonably likely to have or reasonably be expected to result in a Material Adverse Effect.
Appears in 2 contracts
Samples: Stock Purchase Agreement (Cinedigm Corp.), Securities Purchase Agreement (China Broadband Inc)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) of its Subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its SEC Reports Filings and is not so disclosed and or that otherwise would have or reasonably be expected to result in have a Material Adverse Effect.
Appears in 2 contracts
Samples: Note and Warrant Purchase Agreement (RHO Ventures VI LP), Note and Warrant Purchase Agreement (Bluefly Inc)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in the Company’s SEC Reports Documents and is not so disclosed and that otherwise would have or reasonably be expected to result in a Material Adverse Effect.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Starr International Co Inc), Securities Purchase Agreement (China MediaExpress Holdings, Inc.)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in SEC Reports and is not so disclosed and or that otherwise would have or reasonably be expected to result in a Material Adverse Effect.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Anthera Pharmaceuticals Inc), Securities Purchase Agreement (Anthera Pharmaceuticals Inc)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, arrangement or other relationship between the Company (or any Subsidiary) of its Subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in the Company’s SEC Reports Documents and is not so disclosed and disclosed, other than as would not have or reasonably be expected to result in a Material Adverse Effect.
Appears in 2 contracts
Samples: Notes Purchase Agreement (Lumos Networks Corp.), Warrants Purchase Agreement (Lumos Networks Corp.)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in the SEC Reports and is not so disclosed and would have or reasonably be expected to result in a Material Adverse Effect.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Champions Oncology, Inc.), Securities Purchase Agreement (Micromet, Inc.)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in SEC its Continuous Disclosure Reports and is not so disclosed and or that otherwise would be reasonably likely to have or reasonably be expected to result in a Material Adverse Effect.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Dejour Enterprises LTD), Securities Purchase Agreement (Dejour Enterprises LTD)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in the SEC Reports Documents and is not so disclosed and that otherwise would be reasonably likely to have or reasonably be expected to result in a Material Adverse Effect.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Stockeryale Inc), Securities Purchase Agreement (Willbros Group Inc)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, arrangement or other relationship between the Company (or any Subsidiary) its subsidiaries and an unconsolidated or other off off-balance sheet entity that is required to be disclosed by the Company in the SEC Reports and is not so disclosed and or that otherwise would have be reasonably likely to have, individually or reasonably be expected to result in the aggregate, a Material Adverse Effect. There are no such transactions, arrangements or other relationships with the Company that may create contingencies or liabilities that are not otherwise disclosed by the Company in the SEC Reports.
Appears in 2 contracts
Samples: Securities Purchase Agreement (GRANDPARENTS.COM, Inc.), Securities Purchase Agreement (GRANDPARENTS.COM, Inc.)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) subsidiary and an unconsolidated or other off off-balance sheet entity that is required to be disclosed by the Company in its SEC Reports and is not so disclosed and that has had or would have or reasonably be expected expected, individually or in the aggregate, to result in have a Material Adverse Effect.
Appears in 2 contracts
Samples: Subscription Agreement (Transphorm, Inc.), Subscription Agreement (Transphorm, Inc.)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiarysubsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in the SEC Reports and is not so disclosed and would have or reasonably be expected to result in a Material Adverse Effect.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Inhibikase Therapeutics, Inc.), Securities Purchase Agreement (Annexon, Inc.)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiarysubsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in SEC Reports and is not so disclosed and would have or reasonably be expected to result in a Material Adverse Effect.
Appears in 2 contracts
Samples: Subscription Agreement (Korro Bio, Inc.), Securities Purchase Agreement (Avadel Pharmaceuticals PLC)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) its Subsidiary and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its SEC Reports Filings and is not so disclosed and or that otherwise would have or reasonably be expected to result in have a Material Adverse Effect.
Appears in 2 contracts
Samples: Securities Purchase Agreement (RHO Ventures VI LP), Securities Purchase Agreement (Bluefly Inc)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off off- balance sheet entity that is required to be disclosed by the Company in its SEC Reports and is not so disclosed and would have or reasonably be expected to result in a Material Adverse Effectdisclosed.
Appears in 2 contracts
Samples: Stock Purchase Agreement (Riverview Financial Corp), Stock Purchase Agreement (HCSB Financial Corp)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, arrangement or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off off-balance sheet entity that is required to be disclosed by the Company in the SEC Reports and is not so disclosed and or that otherwise would be reasonably likely to have or reasonably be expected to result in a Material Adverse Effect. There are no such transactions, arrangements or other relationships with the Company that may create contingencies or liabilities that are not otherwise disclosed by the Company in the SEC Reports.
Appears in 1 contract
Samples: Purchase Agreement (Comstock Homebuilding Companies, Inc.)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, arrangement or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off off-balance sheet entity that is required to be disclosed by the Company in its SEC Reports and that is not so disclosed and or that otherwise would be reasonably likely to have or reasonably be expected to result in a Material Adverse Effect. There are no such transactions, arrangements or other relationships with the Company that may create contingencies or liabilities that are required to be disclosed by the Company in its SEC Reports and are not otherwise disclosed by the Company in its SEC Reports.
Appears in 1 contract
Samples: Securities Purchase Agreement (Equity Bancshares Inc)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) Subsidiary and an unconsolidated or other off off-balance sheet entity that is required to be disclosed by the Company in its SEC Reports Documents and is not so disclosed and would have or reasonably be expected to result in a Material Adverse Effectdisclosed.
Appears in 1 contract
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in the SEC Reports and that is not so disclosed and would have or reasonably be expected to result in have a Material Adverse Effect.
Appears in 1 contract
Samples: Subscription Agreement (Oriental Financial Group Inc)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its SEC Reports Documents and is not so disclosed and or that otherwise would be reasonably likely to have or reasonably be expected to result in a Material Adverse Effect.
Appears in 1 contract
Samples: Share Subscription Agreement (India Globalization Capital, Inc.)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) , on the one hand, and an unconsolidated or other off balance sheet entity entity, on the other, that is required to be disclosed by the Company in its SEC Reports Documents and is not so disclosed and or that otherwise would be reasonably likely to have or reasonably be expected to result in a Material Adverse Effect.
Appears in 1 contract
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its SEC Reports and is not so disclosed and would have or reasonably be expected to result in a Material Adverse Effectdisclosed.
Appears in 1 contract
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in SEC the Company Reports and is not so disclosed and would have or reasonably be expected to result in a Material Adverse Effectdisclosed.
Appears in 1 contract
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) of its Subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in the SEC Reports and Documents filed at least 10 days prior to the date hereofand is not so disclosed and or that otherwise would be reasonably likely to have or reasonably be expected to result in a Material Adverse Effect.
Appears in 1 contract
Samples: Securities Purchase Agreement (Charys Holding Co Inc)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in the SEC Reports Filings and is not so disclosed and would have or reasonably be expected to result in a Material Adverse Effectdisclosed.
Appears in 1 contract
Samples: Common Stock Purchase Agreement (Cinedigm Digital Cinema Corp.)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in the SEC Reports and that is not so disclosed and would have or reasonably be expected to result in a Material Adverse Effectdisclosed.
Appears in 1 contract
Samples: Securities Purchase Agreement (Bay Banks of Virginia Inc)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) Acquiror and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company Acquiror in its SEC Reports and is not so disclosed and or that otherwise would be reasonably likely to have or reasonably be expected to result in a Material Adverse Effect.
Appears in 1 contract
Samples: Agreement and Plan of Merger (Entorian Technologies Inc)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) Subsidiary and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its SEC Reports Documents and is not so disclosed and or that otherwise would be reasonably likely to have or reasonably be expected to result in a Material Adverse Effect.
Appears in 1 contract
Samples: Line of Credit Agreement (Alternative Construction Company, Inc.)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) of its Subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its SEC Reports Documents and is not so disclosed and or that otherwise would be reasonably likely to have or reasonably be expected to result in a Material Adverse Effect.
Appears in 1 contract
Samples: Securities Purchase Agreement (Dolphin Entertainment, Inc.)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in SEC Reports its Exchange Act filings and is not so disclosed and would have or reasonably be expected to result have, individually or in the aggregate, a Material Adverse Effect.
Appears in 1 contract
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) subsidiary and an unconsolidated or other off off-balance sheet entity that is required to be disclosed by the Company in its SEC Reports (including, for purposes hereof, any that are required to be disclosed in a Form 10) and is not so disclosed and that would otherwise have or reasonably be expected to result in a Material Adverse Effect.
Appears in 1 contract
Samples: Subscription Agreement (Peninsula Acquisition Corp)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, arrangement or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off off-balance sheet entity that is required to be disclosed by the Company in its SEC Reports and Documents that is not so disclosed and would have or reasonably be expected to result in a Material Adverse Effectdisclosed.
Appears in 1 contract
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its SEC Reports and is not so disclosed and would have or reasonably be expected to result in have a Material Adverse Effect.
Appears in 1 contract
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in SEC Reports and is not so disclosed and has had or would have or reasonably be expected to result have, individually or in the aggregate, a Material Adverse Effect.
Appears in 1 contract
Samples: Stock Purchase Agreement (Maxwell Technologies Inc)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in SEC Reports and is not so disclosed and would have or reasonably be expected to result in a Material Adverse Effectdisclosed.
Appears in 1 contract
Off-Balance Sheet Arrangements. There is no transaction, arrangement, arrangement or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off off-balance sheet entity that is required to be disclosed by the Company in its Company SEC Reports Documents and is not so disclosed or that otherwise would be reasonably likely to have a material adverse effect on the Company and would have its subsidiaries, taken as a whole. There are no such transactions, arrangements or reasonably be expected to result other relationships with the Company that may create contingencies or liabilities that are not otherwise disclosed by the Company in a Material Adverse Effectits Company SEC Documents.
Appears in 1 contract
Samples: Investment Agreement (Guaranty Financial Group Inc.)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in SEC its Reports under the Exchange Act and is not so disclosed and that would be reasonably likely to have or reasonably be expected to result in a Material Adverse Effect.
Appears in 1 contract
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the any Existing Company (or any Subsidiary) Entity and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in the SEC Reports and is not so disclosed and would have or reasonably be expected to result in a Material Adverse Effectdisclosed.
Appears in 1 contract
Samples: Securities Purchase Agreement (World Surveillance Group Inc.)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, arrangement or other relationship between the Company (or and/or any Subsidiary) of its Subsidiaries and an unconsolidated or other off off-balance sheet entity that is required to be disclosed by the Company in its SEC Reports Filings and is not so disclosed and or that has or otherwise would have or reasonably be expected to result in have a Material Adverse Effect.
Appears in 1 contract
Samples: Form of Purchase Agreement (New York Mortgage Trust Inc)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) Subsidiary and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in the SEC Reports Filings and is not so disclosed and that would have or reasonably be expected to result in a Material Adverse Effect.
Appears in 1 contract
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its Company SEC Reports Filings and is not so disclosed and or that otherwise would be reasonably likely to have or reasonably be expected to result in a Material Adverse Effect.
Appears in 1 contract
Samples: Secured Convertible Note Purchase Agreement (Searchlight Minerals Corp.)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company Corporation (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company Corporation in SEC Reports its Exchange Act filings and is not so disclosed and would have or reasonably be expected to result in a Material Adverse Effect.
Appears in 1 contract
Samples: Securities Purchase Agreement (Western Alliance Bancorporation)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in SEC Reports its Exchange Act filings and is not so disclosed and would have or reasonably be expected to result in a Material Adverse Effect.
Appears in 1 contract
Samples: Securities Purchase Agreement (Western Alliance Bancorporation)
Off-Balance Sheet Arrangements. There is no material agreement, commitment, transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an any unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its SEC Reports or Financial Statements and is not so disclosed and would have or reasonably be expected to result in a Material Adverse Effectdisclosed.
Appears in 1 contract
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its SEC Reports (including, for purposes hereof, any that are required to be disclosed in a Form 10) and is not so disclosed and or that otherwise would have or could be reasonably be expected to result in have a Company Material Adverse Effect.
Appears in 1 contract
Samples: Securities Purchase Agreement (Twinlab Consolidated Holdings, Inc.)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in the SEC Reports Documents or financial statements and related footnotes according to GAAP and is not so disclosed and would have or reasonably be expected to result in a Material Adverse Effectdisclosed.
Appears in 1 contract
Samples: Convertible Note Purchase Agreement (Clean Energy Fuels Corp.)
